AB
FLNA

Amalgamated Bank’s Filana Therapeutics FLNA Stock Holding History

Amalgamated Bank’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,412
Closed -$2K – 3125
2025
Q1 		$2K Hold
1,412
– – ﹤0.01% 2868
2024
Q4 		$3K Hold
1,412
– – ﹤0.01% 2870
2024
Q3 		$42K Hold
1,412
– – ﹤0.01% 1898
2024
Q2 		$17K Buy
1,412
+87
+7% +$1.83K ﹤0.01% 2198
2024
Q1 		$27K Sell
1,325
-4,289
-76% -$98.8K ﹤0.01% 2029
2023
Q4 		$126K Sell
5,614
-394
-7% -$8.32K ﹤0.01% 1929
2023
Q3 		$100K Hold
6,008
– – ﹤0.01% 1999
2023
Q2 		$147K Buy
6,008
+686
+13% +$16.5K ﹤0.01% 1932
2023
Q1 		$128K Sell
5,322
-802
-13% -$22.2K ﹤0.01% 1956
2022
Q4 		$181K Hold
6,124
– – ﹤0.01% 1898
2022
Q3 		$256K Buy
6,124
+96
+2% +$2.59K ﹤0.01% 1757
2022
Q2 		$170K Sell
6,028
-211
-3% -$5.33K ﹤0.01% 1946
2022
Q1 		$232K Sell
6,239
-495
-7% -$21K ﹤0.01% 1882
2021
Q4 		$294K Sell
6,734
-72
-1% -$3.78K ﹤0.01% 1834
2021
Q3 		$423K Sell
6,806
-418
-6% -$34.9K ﹤0.01% 1672
2021
Q2 		$617K Buy
+7,224
New +$387K ﹤0.01% 1508

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Amalgamated Bank's FLNA Position: Q2 2025 in Review

Amalgamated Bank sold out of Filana Therapeutics (FLNA) in Q2 2025, closing a stake of 1,412 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in FLNA in Q2 2021 and held it in 16 quarters. The position peaked at $617K in Q2 2021. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.

  • Amalgamated Bank reported no remaining Filana Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 1,412 Filana Therapeutics shares in Q2 2025, an estimated $2K.
  • Amalgamated Bank first reported a position in Filana Therapeutics in Q2 2021 and held it in 16 quarters.
  • Amalgamated Bank's Filana Therapeutics position peaked at $617K in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.